Emerging Scientific Evidence Supports Broader Use and Benefits of CGM at the Patient and Population Level

This video reviews recent findings on the use of CGM. The studies highlight real world evidence supporting the broader use and
benefit of CGM at the patient and population level. Key takeaways include:

• The use of CGM has demonstrated clinical utility in non-intensively treated type two diabetes, including individuals using
  non-insulin agents
• CGM has shown an A1c reduction across diverse population who have historically experienced disparities in access to CGM
• CGM has demonstrated a clinical value in individuals also utilizing GLP1
• CGM is linked to reduced mortality in people with type one and type two diabetes using insulin